Executive Summary
The July 10, 2026, digest reveals a market dominated by capital structure engineering and defensive maneuvers, with 50 filings showing a clear bias toward financial restructuring, M&A execution, and governance changes.
A significant theme is the prevalence of going-concern risks and cash preservation strategies, highlighted by InnSuites Hospitality Trust's auditor change citing going concern, ZyVersa Therapeutics' cost-cutting measures including potential 'going dark,' and multiple companies (BSTR Holdings, Faraday Future) relying on dilutive financing to survive. Conversely, a few companies are executing growth strategies, such as DXP Enterprises expanding its credit facility by $40M after a period of strong sales growth (sales rising from $1.1B to $2.1B) and Nuveen Churchill Direct Lending upsizing its debt offering. M&A activity is mixed, with a high-value SPAC merger (RF Acquisition Corp III / HCC Healthcare at $500M pre-money) and a strategic pivot by Nu-Med Plus into gold mining, contrasted by the termination of exclusivity in the Coeptis/Skycore deal. Insider activity is limited but notable, with the CEO and CFO of iQSTEL receiving compensation increases and the executives of ZyVersa taking voluntary pay cuts, signaling divergent management confidence. The overall sentiment is cautious, with a heavy focus on liquidity management and structural changes to address stock price or operational challenges.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from July 09, 2026.
Investment Signals (11)
- DXP Enterprises ↓ (BULLISH)▲
Increased ABL facility by $40M to $225M, reflecting strong growth (sales from $1.1B to $2.1B, net income from $16.4M to $88.1M) and providing ample liquidity for expansion
- RF Acquisition Corp III ↓ (BULLISH)▲
Signed a $500M pre-money business combination with HCC Healthcare, a major player in Taiwan's long-term care market with 9,000+ beds, offering a pure-play exposure to an aging population theme
- Starwood Property Trust ↓ (BULLISH)▲
Closed $500M in 5.875% green bonds, using proceeds to refinance higher-cost 4.375% debt due 2027, improving interest expense profile and ESG credentials
-
Completed acquisition of Avid Gold and agreed to acquire six gold properties, pivoting from medical devices to gold exploration, a high-risk/high-reward diversification play [BULLISH/BEARISH]
- Veritone ↓ (BEARISH)▲
Increased authorized common stock by 25M shares (12.5% dilution), a defensive move that could signal future equity issuance and pressure existing shareholders
- PSQ Holdings ↓ (BEARISH)▲
Announced a 1-for-15 reverse stock split to regain NYSE compliance, a defensive measure that often precedes further price declines and indicates a struggling stock
- Trailblazer Holdings (Cyabra) (BULLISH)▲
Closed a $6.0M PIPE at $0.435/share with insider participation, converting preferred shares to remove a structural overhang, a positive signal for capital structure cleanup
- Sunshine Biopharma ↓ (BEARISH)▲
Paid CAD $1.5M to settle a dispute with a former subsidiary president, a cash outflow with no operational benefit, signaling poor prior M&A integration
- ZyVersa Therapeutics ↓ (BEARISH)▲
Director resigned, executives took pay cuts, and company is considering divesting assets and 'going dark,' indicating severe financial distress and potential equity wipeout
- Crinetics Pharmaceuticals ↓ (BULLISH)▲
Entered a definitive merger agreement to be acquired by Vertex, a high-premium event that will provide a cash exit for shareholders, though non-compete payments to executives are a minor concern
- Faraday Future ↓ (BULLISH)▲
Terminated 5.36M warrants, reducing potential dilution by ~49.9M shares since 2025, a positive step for existing shareholders but still facing substantial funding needs
Risk Flags (10)
- InnSuites Hospitality Trust / Going Concern↓ [HIGH RISK]▼
Auditor change included a going concern explanatory paragraph for fiscal years 2025 and 2026, indicating substantial doubt about the company's ability to continue
- ZyVersa Therapeutics / Financial Distress↓ [HIGH RISK]▼
Director resigned, CEO/CFO took voluntary pay cuts, company considering divesting assets, employee headcount reduction, and 'going dark' by suspending SEC filings
- BSTR Holdings / Pending Merger Risk↓ [MEDIUM RISK]▼
Increased loan by $1M to fund operations for a pending business combination with Cantor Equity Partners, but parties are discussing a 'potential revised structure,' adding uncertainty to the deal
- Cadrenal Therapeutics / Key Person Risk↓ [MEDIUM RISK]▼
Chief Medical Officer resigned effective July 31, 2026, creating leadership uncertainty during a critical clinical development period
- Sunshine Biopharma / Legal Settlement↓ [MEDIUM RISK]▼
Paid CAD $1.5M to settle a dispute with a former subsidiary president, releasing him from non-compete obligations, which could harm the business
- PSQ Holdings / Reverse Stock Split↓ [MEDIUM RISK]▼
1-for-15 reverse split to regain NYSE listing compliance, a defensive move that often signals a struggling business and can lead to further price declines
- Veritone / Dilution Risk↓ [MEDIUM RISK]▼
Increased authorized common stock by 25M shares (12.5%), paving the way for potential equity issuance that could dilute existing shareholders
- Air T Inc / ATM Offering↓ [MEDIUM RISK]▼
Entered into an at-the-market offering for up to $8M in common stock, which could lead to dilution and downward price pressure
- Peraso Inc / Dilutive Financing↓ [MEDIUM RISK]▼
Adjusted purchase price discount for a common stock purchase agreement, a condition for commencing sales under a potentially dilutive equity facility
- Team Inc / Severance Reduction↓ [LOW RISK]▼
Reduced change-in-control severance benefits for executives, which could make it harder to retain key talent during a potential acquisition or restructuring
Opportunities (10)
- RF Acquisition Corp III / SPAC Merger↓ (OPPORTUNITY)◆
The $500M pre-money merger with HCC Healthcare offers exposure to the growing long-term care market in Taiwan. The deal is expected to close in Q4 2026, providing a catalyst for SPAC shareholders
- DXP Enterprises / Credit Expansion↓ (OPPORTUNITY)◆
The $40M increase in its ABL facility to $225M, coupled with strong historical growth (sales doubled, net income up 5x), positions the company for further organic and M&A growth
- Starwood Property Trust / Green Bond Refinancing↓ (OPPORTUNITY)◆
The $500M green bond issuance at 5.875% to refinance 4.375% notes due 2027 is a credit-positive move, improving the company's debt maturity profile and potentially lowering interest costs
- Crinetics Pharmaceuticals / Merger Arbitrage↓ (OPPORTUNITY)◆
The definitive agreement to be acquired by Vertex provides a near-term cash exit. The deal is high materiality (9/10) and offers a potential arbitrage opportunity if the spread is wide enough
- Nu-Med Plus / Gold Exploration Pivot↓ (OPPORTUNITY)◆
The acquisition of Avid Gold and six properties in Atlantic Canada provides a speculative play on gold prices. The company's pivot from medical devices to mining could unlock value if exploration is successful
- Trailblazer Holdings (Cyabra) / Capital Structure Cleanup (OPPORTUNITY)◆
The $6.0M PIPE with insider participation and conversion of preferred shares removes a structural overhang, potentially setting the stage for a re-rating if the company executes on its business plan
- Nuveen Churchill Direct Lending / Debt Upsize↓ (OPPORTUNITY)◆
The $100M add-on to its 6.650% Notes due 2030, upsizing the total to $400M, demonstrates strong access to capital markets and provides funds for investment, supporting dividend coverage
- Lincoln Educational Services / Property Acquisition↓ (OPPORTUNITY)◆
The $15M loan to finance a property acquisition suggests expansion of its campus footprint, which could drive future enrollment growth
- Skillsoft Corp / Divestiture Catalyst↓ (OPPORTUNITY)◆
The sale of its Global Knowledge Training business for up to $15.4M allows the company to focus on its core digital learning platform, potentially improving margins and growth profile
- Faraday Future / Dilution Reduction↓ (OPPORTUNITY)◆
The termination of 5.36M warrants, part of a cumulative 49.9M share reduction since 2025, is a positive signal for existing shareholders, reducing overhang and showing investor support
Sector Themes (6)
- Capital Structure Engineering Dominates◆
A significant portion of filings (Faraday Future, PSQ Holdings, Veritone, Air T, Peraso, Trailblazer Holdings) involve actions to manage capital structure, including reverse splits, authorized share increases, warrant cancellations, and at-the-market offerings. This suggests many companies are struggling with low stock prices and are using financial engineering to maintain listings or raise cash.
- M&A Activity with Execution Risk◆
Several M&A deals are in progress (RF Acquisition/HCC, BSTR/Cantor, Coeptis/Skycore, Nu-Med Plus/Avid Gold), but many show signs of stress, such as deadline extensions, revised structures, and terminated exclusivity. This indicates a challenging M&A environment where deals are taking longer to close and face higher uncertainty.
- Going Concern and Financial Distress Signals◆
Multiple filings (InnSuites, ZyVersa, BSTR Holdings) contain explicit or implicit going concern warnings, highlighting a subset of micro-cap companies facing severe liquidity pressures. The prevalence of these signals suggests a broader stress in the small-cap space.
- Governance and Board Changes as a Constant◆
A large number of filings (Alpha & Omega, Trump Media, Sterling Infrastructure, Lee Enterprises, Freedom Holding, Enova, Axon, etc.) involve director or officer changes. While many are routine, the sheer volume indicates a period of active board refreshment and succession planning across the market.
- Shift to Alternative Assets and Diversification◆
Nu-Med Plus's pivot to gold mining and iQSTEL's internal realignment into fintech/AI highlight a trend of small-cap companies diversifying into higher-growth or alternative sectors to escape stagnant core businesses. This carries high execution risk but offers potential upside.
- Debt Market Access Remains Open for Quality◆
While some companies struggle, others like DXP Enterprises, Starwood Property Trust, and Nuveen Churchill Direct Lending successfully accessed debt markets to refinance or expand, demonstrating that credit is available for companies with strong fundamentals and clear use of proceeds.
Watch List (8)
-
Watch for shareholder vote and SEC effectiveness of Form F-4. Expected close in Q4 2026. A successful close would create a unique publicly traded long-term care operator.
-
Monitor for further details on asset divestitures (VAR 200, IC 100), employee reductions, and potential 'going dark' filing. The situation is highly fluid and could lead to a total loss for equity holders.
-
Watch for the outcome of discussions on a 'potential revised structure' for the business combination. The increasing loan size and uncertainty around the deal structure are key risk factors.
-
Monitor for shareholder approval and regulatory clearance. The deal is expected to close, providing a near-term catalyst for Crinetics shareholders.
-
The 1-for-15 reverse split is effective July 13, 2026. Watch for the stock's trading behavior post-split and whether it successfully regains NYSE compliance.
-
Monitor for exploration results from the newly acquired properties in Atlantic Canada. The company's pivot to gold mining is a high-risk, high-reward catalyst.
-
Watch for the company's next earnings report to assess the impact of the Global Knowledge sale on margins and revenue growth for the continuing digital learning business.
-
The resignation of the CMO effective July 31, 2026, creates a key person risk. The speed and quality of the replacement search will be critical for the company's clinical programs.
Filing Analyses
(50)
10-07-2026
Faraday Future announced the termination of 5.36 million warrants with investors, bringing cumulative warrant cancellations to approximately 49.9 million shares since 2025, significantly reducing potential dilution. The company also amended its July 2025 securities purchase agreement to optimize the closing structure, removing warrant issuance for certain investors in subsequent closings and dividing the second closing into eight tranches, each requiring at least $5 million in additional funding. These actions reflect investor support and aim to accelerate capital deployment for the company's robotics Three-in-One business, though the company continues to face substantial funding needs and operational risks.
- · The original July 2025 securities purchase agreement provided for two closings; the first was completed on August 22, 2025.
- · Under the amended agreement, certain investors will no longer receive common stock purchase warrants in subsequent closings.
- · The VWAP condition to closing has been removed from subsequent closings.
- · The company intends to continue optimizing its balance sheet and selecting financing approaches to unlock long-term value and introduce strategic investors.
10-07-2026
RF Acquisition Corp III (RFAM) has signed a Business Combination Agreement with HCC Healthcare Pte. Ltd., a Singapore-based integrated medical and long-term care services provider operating in Taiwan. The transaction values HCC Healthcare at approximately $500 million pre-money and is expected to close in Q4 2026, subject to shareholder approval, SEC effectiveness of the Form F-4, and other conditions. Post-closing, HCC Healthcare will list on Nasdaq, aiming to use the proceeds to accelerate consolidation and expansion of its care network; however, the deal carries standard risks including failure to obtain approvals, shareholder redemptions, and execution risks related to integrating affiliated providers and deploying AI technology.
- · The BCA reflects a pre-transaction equity value of HCC Healthcare of approximately US$500 million.
- · Transaction expected to close in Q4 2026, subject to shareholder approval, SEC effectiveness of Form F-4, and customary closing conditions.
- · Pro forma combined network encompasses more than 120 long-term care facilities and over 9,000 beds, including one institution with more than 1,300 beds.
- · Group provides case management for more than 7,000 individuals, with operations concentrated in Northern Taiwan (approximately one-third of Taiwan's population).
- · Strategic growth roadmap includes four priorities: AI platform, Japan market entry, wellness partnerships, and precision/regenerative medicine.
- · Certain operational information is presented on a combined or pro forma basis and includes affiliated and allied providers not wholly owned or consolidated.
- · No amounts or percentages are provided for historical financial performance or period-over-period comparisons.
10-07-2026
La Rosa Holdings Corp. filed a Certificate of Designation to create 10,000 shares of Series E Convertible Preferred Stock, each convertible into common shares at $1.58 per share. The new series ranks senior to common stock and junior to any future senior preferred stock, and the company is restricted from issuing certain junior stock with a redemption date before the second anniversary of the initial issuance. This financing move provides the company with additional capital flexibility but also introduces potential dilution for existing common shareholders.
- · The Series E Convertible Preferred Stock ranks senior to common stock (Junior Stock) and on parity with any Parity Stock, but junior to any future Senior Preferred Stock.
- · The company is prohibited from issuing any Junior Stock with a maturity or redemption date prior to the second anniversary of the initial issuance date without holder consent.
- · Conversion mechanics require the company to deliver conversion shares within one trading day of a conversion notice, with a buy-in penalty if the company fails to deliver on time.
- · No shares of Series E Convertible Preferred Stock have been issued as of the filing date.
10-07-2026
InnSuites Hospitality Trust (IHT) changed its independent auditor after BCRG Group was acquired by Simon & Edward LLP. The Audit Committee dismissed BCRG and appointed S&E effective July 9, 2026. BCRG's audit reports for fiscal years ended January 31, 2026 and 2025 contained no adverse opinion but included a going concern explanatory paragraph, indicating substantial doubt about the Trust's ability to continue as a going concern.
- · The change in auditor was triggered by S&E's acquisition of BCRG's attest business effective June 15, 2026.
- · No disagreements or reportable events occurred between the Trust and BCRG during the fiscal years ended January 31, 2026 and 2025 or the subsequent interim period.
- · The Trust did not consult S&E on any accounting or auditing matters prior to engagement.
- · BCRG provided a letter to the SEC agreeing with the Trust's statements, dated July 9, 2026.
10-07-2026
BSTR Newco, LLC, a subsidiary of BSTR Holdings, Inc., entered into Amendment No. 2 to its Loan Agreement with BSTR Holdings (Cayman) on July 8, 2026, increasing the principal sum by $1,000,000 to a total of $4,600,000. The loan, originally $2,500,000 and previously amended to $3,600,000, bears interest at SOFR plus 3.90% and is intended to fund operating costs and transaction expenses related to a pending business combination with Cantor Equity Partners I, Inc. The parties are also discussing a potential revised structure and amended terms for the business combination, adding uncertainty to the transaction.
- · The loan is intended to fund Newco's operating costs from January 1, 2026, and transaction expenses related to the pending business combination.
- · Interest is payable annually beginning on the first anniversary of the Loan Agreement (March 15, 2027).
- · The unpaid balance and accrued interest are due upon the earliest of: consummation of the business combination, dissolution of Newco, or two years from signing (March 15, 2028).
- · Newco may prepay the principal at any time without premium or penalty.
- · The parties are discussing a potential revised structure and amended terms for the business combination (Proposed Amended Transaction), which may result in additional SEC filings.
- · The Registration Statement on Form S-4 was declared effective by the SEC on June 5, 2026.
10-07-2026
DXP Enterprises increased its asset-based revolving credit facility (ABL) from $185 million to $225 million, adding $40 million in borrowing capacity. The facility matures on July 2, 2031, and can be further increased by up to $50 million. The company highlighted strong growth from 2021 to the last twelve months ending March 31, 2026, with sales rising from $1.1 billion to $2.1 billion and net income from $16.4 million to $88.1 million. No negative or flat metrics were reported in this filing.
- · The ABL Facility matures on July 2, 2031.
- · Interest rates: Term SOFR or Term CORRA plus 1.25% to 1.75% per annum, or alternate base rate plus 0.25% to 0.75% per annum, based on average daily excess availability.
- · The facility can be further increased by up to $50 million in minimum increments of $10 million.
- · The company operates in the United States, Canada, Mexico, and Dubai.
- · Business segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services.
10-07-2026
Eureka Acquisition Corp (EURKU) issued a $8,253.03 promissory note to Marine Thinking Inc. on July 7, 2026, to fund working capital in connection with a potential business combination. The note is non-interest bearing, convertible into units at $10.00 per unit upon a business combination, and is repayable only from funds outside the trust account if no deal closes. This small loan signals ongoing efforts to consummate a merger, but the amount is minimal relative to typical SPAC trust sizes.
- · The note is non-interest bearing, with default interest at the prevailing short-term U.S. Treasury Bill rate.
- · Conversion right allows Marine Thinking Inc. to convert the note into units at $10.00 per unit, with no fractional units issued.
- · The note is repayable only from funds outside the trust account if no business combination occurs.
- · The note matures upon the earlier of a business combination or the expiry of the company's term.
- · The filing references the company's prospectus (File No. 333-277780).
10-07-2026
Alpha and Omega Semiconductor Limited (AOSL) appointed Joshua Chien as an independent director on July 8, 2026, effective immediately. Mr. Chien brings extensive experience in business development, supply chain strategy, and operational leadership from roles at Sonatus, SMTC Corporation, and Sanmina Corporation. The appointment is part of the company's efforts to strengthen its board and execute strategic priorities.
- · Joshua Chien served as Chief Commercial Officer of SMTC Corporation from 2021 to April 2026, achieving more than fourfold revenue growth.
- · He currently serves as Executive Vice President, Product & Strategy Officer at Sonatus, Inc., an AI-enabling mobility software company.
- · Mr. Chien holds a Bachelor of Arts in Economics from UC Berkeley and completed the Finance for Executives program at Harvard Business School.
10-07-2026
Stabilis Solutions, Inc. disclosed on Form 8-K that it dismissed HL&B as its independent registered public accounting firm and engaged CohnReznick as its new certifying accountant. The auditor change was approved by the Audit Committee on July 8, 2026; there were no disagreements or reportable events with HL&B during fiscal years 2024, 2025, or the subsequent interim periods, and the Company did not consult CohnReznick on any accounting or audit-related matters prior to the change.
- · The auditor change was approved by the Audit Committee on July 8, 2026.
- · During fiscal years ended December 31, 2025 and 2024, and subsequent interim periods through the filing date, there were no disagreements or reportable events as defined under Regulation S-K Item 304 with HL&B.
- · Neither the Company nor anyone on its behalf consulted CohnReznick on any matter involving the application of accounting principles to a specified transaction or the type of audit opinion that might be rendered.
10-07-2026
Cadrenal Therapeutics, Inc. (CVKD) announced the resignation of Chief Medical Officer Dr. James J. Ferguson III, effective July 31, 2026. The company has initiated a search for a replacement and is negotiating a separation agreement. The departure of a key officer introduces leadership uncertainty during a critical period for the company's clinical development.
- · Dr. Ferguson's resignation was announced on July 7, 2026, with an effective date of July 31, 2026.
- · The separation agreement and release are still being negotiated and have not yet been finalized.
- · The company is actively searching for a replacement Chief Medical Officer.
10-07-2026
Veritone, Inc. filed a Certificate of Amendment to its Fourth Amended and Restated Certificate of Incorporation on July 10, 2026, increasing the authorized common stock from 200,000,000 shares to 225,000,000 shares and reducing the authorized preferred stock from 10,000,000 shares to 1,000,000 shares. The amendment was approved by the board of directors and stockholders and takes effect upon filing. The filing also covers director/officer departure/election matters under Items 5.02, 5.03, 5.07, and 9.01.
- · The amendment was effective upon filing on July 10, 2026.
- · The filing also reports on Items 5.02, 5.03, 5.07, and 9.01, which typically cover director/officer changes, amendment to articles of incorporation, submission of matters to a vote of security holders, and financial statements/exhibits, respectively.
- · No financial results or specific director/officer departure/election details were provided in the accessible content; only the charter amendment exhibit was included.
10-07-2026
On July 6, 2026, George Holding resigned from the Board of Directors of Trump Media & Technology Group Corp., effective immediately. His resignation did not arise from any dispute with management or the Board. The company expressed gratitude for his service.
- · Resignation was effective immediately on July 6, 2026.
- · Mr. Holding also resigned from all committees on which he served.
- · The resignation was not related to any dispute with management or the Board.
10-07-2026
Sterling Infrastructure, Inc. announced that Mark D. Wolf, its General Counsel, Chief Compliance Officer and Corporate Secretary, notified the company of his intention to retire later this year. Mr. Wolf is expected to continue in his current role and assist in the transition.
- · The retirement notification was made on July 6, 2026.
- · Mr. Wolf will continue in his current role and assist in the transition.
10-07-2026
Mary Junck informed the Board of Lee Enterprises that she is retiring from the Board effective July 31, 2026. The departure is not due to any disagreements with the company. No financial impact or other material changes were disclosed.
- · Mary Junck's retirement is effective July 31, 2026.
- · No disagreements exist between Junck and the company regarding operations, policies, or practices.
10-07-2026
PSQ Holdings, Inc. announced a 1-for-15 reverse stock split effective July 13, 2026, intended to increase the per-share price of its Class A common stock to regain compliance with the NYSE minimum share price requirement and potentially qualify for Russell US Index eligibility. The split reduces outstanding shares from 50,349,974 to approximately 3,356,664 and adjusts warrants proportionally. While the company frames this as a structural cleanup that does not change strategy or stockholder value, the reverse split is a defensive measure to address a low stock price and maintain exchange listing.
- · The reverse stock split is effective July 13, 2026, with trading on a split-adjusted basis beginning at market open that day under the same ticker 'PSQH' but a new CUSIP number (693691 206).
- · No fractional shares will be issued; stockholders entitled to fractional shares will receive cash in lieu.
- · The total number of authorized shares of Class A common stock remains unchanged.
- · Inclusion in any Russell US index is not guaranteed and depends on market capitalization ranking and other criteria.
10-07-2026
Crinetics Pharmaceuticals has entered into a definitive merger agreement to be acquired by Vertex Pharmaceuticals Incorporated, with the company surviving as a wholly owned subsidiary of Vertex. In connection with the merger, Crinetics entered into non-compete agreements with four key executives, including CEO R. Scott Struthers, CFO Tobin Schilke, Chief Scientific Officer Stephen Betz, and Chief Commercial Officer Isabel Kalofonos. The non-compete agreements provide for cash payments totaling $200,000 to three of the executives (Schilke, Betz, and Kalofonos) upon closing, while CEO Struthers receives no additional cash consideration under these agreements.
- · The merger agreement was entered into on July 6, 2026, and the non-compete agreements were entered into on the same date.
- · The non-compete agreements restrict the executives from performing services for certain named businesses in territories where Crinetics operates for one year post-closing.
- · CEO R. Scott Struthers is included in the non-compete agreements but is not listed as receiving a cash payment for the non-compete.
- · The form of non-compete agreement will be filed as an exhibit to the company's Quarterly Report on Form 10-Q for the period ending September 30, 2026.
- · The filing includes a solicitation statement under Rule 14a-12, indicating active solicitation of stockholder approval for the merger.
10-07-2026
InMed Pharmaceuticals and Mentari Therapeutics announced an amendment to their all-stock merger agreement and the filing of a registration statement on Form S-4 with the SEC. The amendment clarifies the sequencing of transactions, the impact of pre-closing financing on the exchange ratio, and the intended tax treatment. The merger is expected to close in Q4 2026, subject to shareholder approvals and regulatory effectiveness.
- · Mentari's lead programs target PACAP, a newly validated target for migraine prevention.
- · Mentari's pipeline includes MT-001 and MT-002, discovered by Paragon Therapeutics.
- · The S-4 has been filed but not yet declared effective by the SEC.
- · InMed's pipeline includes programs for Alzheimer's, ocular, and dermatological indications.
10-07-2026
MDWerks, Inc. (OTCQB: MDWK) announced the appointment of Jeff Hopmayer to its Board of Directors as the company transitions from technology development to commercial execution. The company reports an independently appraised IP portfolio valued at approximately $400 million, signed commercial contracts, and initial customer deployments beginning in Q2 2026, with estimated addressable markets exceeding $1.8 trillion globally. However, the filing contains no current revenue or profit figures, and the company remains in an early commercial stage with no disclosed financial performance metrics.
- · First commercial deployment of the Molecular Sawdust Drying System (MSDS) has recently begun.
- · Customer deployments began in Q2 2026.
- · The company's patent estate includes issued and pending patents worldwide.
- · MDWerks initially commercialized its platform in the beverage alcohol industry for flavor enhancement and extraction.
- · Potential applications include desalination, water purification, wastewater treatment, chemical extraction, food production, pharmaceuticals, agriculture, engineered materials, and advanced manufacturing.
10-07-2026
Cyabra, Inc. (Nasdaq: CYAB) announced a $6.0 million private placement priced at $0.435 per share and accompanying warrants, with participation from new and existing institutional investors, management, and board members. Concurrently, all outstanding preferred shares will convert into common stock (or equivalents) at $0.435 per share, and a Series C preferred holder will exchange $10.66 million of preferred stock for securities in the placement. The company expects the transactions to remove a structural overhang and improve its capital structure, though all conversions and the exchange are subject to stockholder approval.
- · Series A Warrants have an exercise price of $0.50 per share, exercisable upon stockholder approval, expiring 5 years from initial exercise date.
- · Series B Warrants have an exercise price of $0.45 per share, exercisable upon stockholder approval, expiring 12 months from initial exercise date.
- · The private placement is priced at a premium to the market price.
- · Closing expected on or about July 10, 2026, subject to customary closing conditions.
- · Net proceeds will be used for working capital and general corporate purposes.
- · A.G.P./Alliance Global Partners is the sole placement agent.
- · The offering is exempt from registration under Section 4(a)(2) of the Securities Act and/or Regulation D.
- · The company will file a resale registration statement with the SEC for the shares and underlying warrant shares.
10-07-2026
Z Squared Inc. amended its letter of intent to acquire Skycore Digital LLC, extending the drop dead date to January 15, 2027, eliminating a $500,000 break-up fee, and terminating exclusivity. The LOI remains non-binding, and there is no assurance the acquisition will be consummated.
- · Drop dead date extended from June 30, 2026 to January 15, 2027.
- · Exclusivity provisions terminated; discussions are now non-exclusive.
- · The LOI, as amended, is non-binding except for confidentiality, governing law, and dispute resolution.
10-07-2026
Enova International announced the appointment of Maria Veltre to its Board of Directors, effective immediately, while William M. Goodyear and Mark McGowan retired as part of a planned board transition. The changes are not related to any disagreement with the company. The announcement also references the company's pending acquisition of Grasshopper Bank.
- · Maria Veltre is an Operating Partner at Lightyear Capital and previously served as US Head of Digital and Innovation at Santander US, CMO for Fifth Third Bank and Citi's Small Business unit.
- · William M. Goodyear and Mark McGowan resigned as part of a planned board transition, with no disagreement with the company.
- · Enova has provided approximately $70 billion in loans and financing to nearly 15 million customers over 20+ years.
10-07-2026
On July 8, 2026, Dr. Kairat Kelimbetov resigned from the Board of Directors of Freedom Holding Corp., effective immediately, reducing board size from seven to six directors. The resignation was not due to any disagreement with the company's operations, policies, or practices. No financial impact or other material changes were disclosed.
- · Resignation effective immediately on July 8, 2026.
- · Board size decreased from 7 to 6 directors.
- · No disagreement cited as reason for resignation.
10-07-2026
Nu-Med Plus, Inc. (NUMD) announced the acquisition of Avid Gold Ltd and its subsidiary Maritimes Gold Corp., and a separate agreement to acquire six gold properties in Atlantic Canada from MegumaGold Corp. The company is diversifying from its medical device business into gold exploration and development. The acquisition of the properties is subject to conditions including MegumaGold shareholder approval, and the company faces risks related to financing, dilution, and the uncertainty of mineral recovery.
- · The acquisition of Avid Gold is completed; the acquisition of the six gold properties from MegumaGold is subject to conditions including MegumaGold shareholder approval.
- · The properties span more than 30,900 acres in Nova Scotia, New Brunswick, and Newfoundland and Labrador, with four located in the Meguma Terrane.
- · Fred Tejada brings over 40 years of international mining experience and will lead gold exploration.
- · The company's shares are quoted on the OTCQB Venture Market.
- · Risks include the need for additional financing, potential dilution from convertible preferred stock, and no assurance that minerals will be recovered economically.
10-07-2026
On July 7, 2026, the Board of Directors of Team, Inc. approved an amendment to its Corporate Executive Officer Compensation and Benefits Continuation Policy, reducing change-in-control severance benefits. The amendment caps supplemental salary payments at 24 months (down from longer periods) and modifies the calculation of supplemental compensation for forgone bonuses to use the higher of the most recent year's actual bonus or the two-year average, or target bonus if none paid. This change reduces potential executive payout obligations but does not involve any director or officer departure or election.
- · The amendment applies only to Section III of the Policy (Severance Benefits for Involuntary Separation from Service Without Cause or Voluntary Separation from Service for Good Reason Related to Change in Control).
- · Supplemental compensation for forgone annual incentive/bonus is now calculated using the higher of the most recent year's actual bonus or the two-year average; if no bonus has been received, target bonus is used.
- · The supplemental compensation payment is made as a single lump sum on the same date as the supplemental salary payment.
- · The amendment does not affect other sections of the Policy or other compensatory arrangements.
10-07-2026
Adient plc announced on July 6, 2026, that EVP and CFO Mark Oswald intends to leave the company by December 31, 2026, with no disagreement over operations, policies, or practices. The company has initiated an external search for a new CFO. No financial figures or performance metrics are provided in this filing.
- · Departure is not due to any disagreement with the company regarding operations, policies, or practices.
- · External search for next CFO has been initiated.
- · Mr. Oswald's last day is no later than December 31, 2026.
10-07-2026
Ainos, Inc. dismissed its independent registered public accounting firm YCM CPA INC. on July 9, 2026, following the expiration of its engagement, and simultaneously engaged DLEE Accountancy, Inc. as its new auditor. The company reported no disagreements or reportable events with YCM during the most recent fiscal year and through the dismissal date. The change appears routine and amicable, with no adverse accounting or audit issues disclosed.
- · No disagreements on accounting principles, financial statement disclosure, or auditing scope with YCM.
- · No reportable events as defined in Item 304(a)(1)(v) of Regulation S-K.
- · The company did not consult DLEE on any audit opinion, disagreement, or reportable event prior to engagement.
- · The change was effective July 9, 2026, and the 8-K was filed July 10, 2026.
10-07-2026
On July 8, 2026, Axon Enterprise appointed Vivek Mohindra and Eiso Kant to its Board of Directors, effective immediately, to fill existing vacancies. Both are independent directors with terms expiring at the 2027 annual meeting. The appointments bring senior leadership experience from Dell Technologies and AI-focused startups, respectively, but no financial performance data is included in this filing.
- · Mr. Mohindra, 57, served at Dell Technologies from May 2020 to April 2026, most recently as Special Advisor to the Vice Chair and COO.
- · Mr. Kant, 35, is co-founder and CTO of poolside, and since July 2025 also co-CEO; he also co-founded and leads Poolside Infrastructure Company.
- · Mr. Mohindra holds a Ph.D. and M.S. in Chemical Engineering and an M.B.A. from MIT, and a B.E. from IIT Roorkee.
- · Mr. Kant studied business administration at IE University in Madrid, Spain.
- · No transactions requiring disclosure under Item 404(a) of Regulation S-K were identified for either director.
10-07-2026
Skillsoft Corp. completed the sale of its Global Knowledge Training LLC business (instructor-led training) to an affiliate of Enduring Ventures for total consideration of up to approximately $15.4 million. The deal includes an initial consideration of about $5.4 million paid via promissory note, $10.0 million in deferred consideration (minus ~$2.0 million for employee liabilities) payable quarterly starting nine months after closing, plus contingent consideration. Pro forma financials show the continuing operations generated a net loss of $18.5 million (or $2.10 per share) for the three months ended April 30, 2026, and an $84.4 million net loss (or $9.82 per share) for fiscal year ended January 31, 2026.
- · The deferred consideration of $10.0M is reduced by approximately $2.0M related to long-term employee liabilities.
- · The promissory note for the initial consideration is secured by the Company’s cash and accounts receivable.
- · The Buyer’s obligation to pay deferred consideration is guaranteed by the Company and secured by the Transferred Companies’ intellectual property rights.
- · GK business was previously classified as discontinued operations; pro forma adjustments also remove historical operating results for FY2024, FY2025, and FY2026.
- · Transaction accounting adjustments in the pro forma statement of operations for FY2026 include $1.23M of interest income on the promissory note.
- · Pro forma long-term debt remains high at $568.2M as of April 30, 2026.
10-07-2026
Origin Materials, Inc. filed a Certificate of Designation creating one share of Series A Junior Preferred Stock, which carries limited voting rights tied to a dissolution vote and ranks senior to common stock upon liquidation. The share is non-transferable without board consent and pays no dividends, with a liquidation preference of $0.01. This appears to be a structural governance move, likely a poison pill or dissolution-related mechanism, with no immediate financial impact.
- · The Series A Junior Preferred Stock has no dividend rights.
- · The share is uncertificated and non-transferable without prior board consent.
- · Voting rights are limited to dissolution matters and are cast proportionally to common stock votes.
- · Any amendment to the Certificate of Designation requires the holder's approval as a separate class.
10-07-2026
Starwood Property Trust, Inc. closed a private offering of $500 million aggregate principal amount of 5.875% unsecured senior notes due 2029 on July 10, 2026. The net proceeds will be allocated to eligible green and/or social projects, with pending allocation used to redeem up to all of its $500 million 4.375% Senior Notes due 2027 or for general corporate purposes. The notes are senior unsecured obligations, mature on August 15, 2029, and bear interest semi-annually.
- · The notes were issued in a private offering exempt from registration under Rule 144A and Regulation S.
- · Interest on the notes will be paid semi-annually on February 15 and August 15, commencing February 15, 2027.
- · The notes are subject to a Springing Guarantee Covenant that may require certain domestic subsidiaries to guarantee the notes under specified conditions.
- · The indenture includes covenants limiting additional indebtedness and requiring Total Unencumbered Assets of at least 120% of outstanding Unsecured Indebtedness.
- · Certain covenants automatically terminate if the notes achieve investment-grade ratings from two or three selected rating agencies and no default is continuing.
- · Prior to May 15, 2029, the company may redeem notes at a make-whole premium; on or after that date, at par plus accrued interest.
- · Up to 40% of the notes may be redeemed at 105.875% of principal using equity offering proceeds before May 15, 2029.
- · A change of control triggering event requires the company to offer to repurchase notes at 101% of principal plus accrued interest.
10-07-2026
Cerus Corporation filed an 8-K disclosing that William 'Obi' Greenman, former President and CEO, transitioned to Executive Chairman effective July 1, 2026, and entered into an amendment to his existing employment letter agreement on July 6, 2026. Under the amendment, he will receive an annual base salary of $500,000 and a 2026 target cash bonus of 80% of his 2026 base salary, but will not be eligible for a 2027 cash bonus. His anticipated time commitment is about 60% of full-time, and the role ends on May 31, 2027, unless extended.
- · The Executive Chairman role is anticipated to require a time commitment averaging about 60% of a full-time schedule.
- · Mr. Greenman's service as Executive Chairman ends on May 31, 2027, unless earlier terminated or extended by written agreement.
- · The amendment specifies that Mr. Greenman will not be entitled to an annual cash bonus for any portion of 2027.
- · The company will pay or reimburse COBRA premiums if Mr. Greenman's Executive Chairman service constitutes a qualifying event under COBRA and he remains compliant with the agreement.
10-07-2026
On July 6, 2026, The Children's Place, Inc. announced that Kim Roy stepped down as Executive Director and employee, effective immediately, but will remain on the board. Her departure was not due to any disagreement with the company. A separation agreement is still being negotiated and will be disclosed in a future amendment.
- · The separation agreement has not yet been finalized; terms will be disclosed in an amendment to this 8-K.
- · Ms. Roy's departure was not the result of any disagreement with the company regarding operations, policies, or practices.
10-07-2026
iQSTEL Inc. amended the employment agreements of its CEO and CFO on July 7, 2026, increasing CEO monthly base salary from $31,000 to $37,800 (including a relocation allowance) and granting a two-month cash performance bonus for relocation expenses. The board also approved equity compensation changes—replacing annual common stock grants with up to 50,000 Series B Preferred Shares per executive per year and granting 20,000 Series B Preferred Shares to the CEO and 14,000 to the CFO for FY-2025—but these equity changes are subject to shareholder approval under Nasdaq rules and will not take effect until approved. No financial results or period-over-period comparisons are provided in this filing.
- · The equity compensation changes are subject to shareholder approval under Nasdaq Listing Rule 5635(c) and will not become effective until approved.
- · The annual bonus payment timing was amended to allow payment 15 days after filing the 10-K.
- · The previous annual equity incentive allowed up to 1,000,000 common shares for the CEO and 800,000 common shares for the CFO; these were replaced with Series B Preferred Shares.
10-07-2026
Air T, Inc. entered into an At the Market Offering Agreement with Ascendiant Capital Markets, LLC on July 10, 2026, allowing the company to sell up to $8,000,000 of its common stock through an at-the-market offering. The company will pay a 3.0% placement fee on gross sales. This filing does not contain any period-over-period financial performance data, so no balanced comparison is possible.
- · The Sales Agreement was filed as Exhibit 10.1 to the Form 8-K.
- · The offering is made under the company's shelf registration statement on Form S-3 (File Nos. 333-277855 and 333-277855-01), effective March 27, 2024.
- · Sales may be made on The Nasdaq Capital Market or in privately negotiated transactions with prior approval.
- · The company is not obligated to make any sales under the agreement.
- · The opinion of Winthrop & Weinstine, P.A. regarding the legality of the shares is filed as Exhibit 5.1.
10-07-2026
O'Reilly Automotive appointed Colin Yankee as Executive Vice President and Chief Supply Chain Officer, effective July 13, 2026. Mr. Yankee brings over 20 years of retail supply chain experience from Tractor Supply Company, Neiman Marcus, and Target. His compensation includes a $700,000 base salary, an 85% annual incentive target, and a $500,000 hiring stock option award.
- · Mr. Yankee will be responsible for merchandise, inventory management, distribution operations, and transportation.
- · He will receive a stock option award with estimated future fair value of 100% of his annual base salary, granted at the same time as other executive officers.
- · He is eligible for other benefits and perquisites substantially similar to other executive officers.
- · The company entered into a change in control severance agreement with Mr. Yankee on same terms as other executive officers.
- · No family relationships or material transactions with the company were disclosed.
10-07-2026
O-I Glass, Inc. announced an organizational change on July 8, 2026, under which Emmanuelle Guérin will step down as Senior Vice President, Business Operations Europe, effective immediately. She will remain a non-executive employee on garden leave through September 30, 2026, receiving continued salary and benefits, and will be eligible for severance under the company's Executive Severance Policy. The filing does not disclose any financial impact or replacement, and no period-over-period comparisons are provided.
- · Emmanuelle Guérin's employment will terminate on September 30, 2026.
- · She is entitled to continuation of current salary and benefits through September 30, 2026.
- · Severance eligibility is under O-I Glass, Inc.'s Amended and Restated Executive Severance Policy.
- · No successor or interim replacement for the role has been announced.
10-07-2026
Nuveen Churchill Direct Lending Corp. (NCDL) issued an additional $100.0 million in aggregate principal amount of its 6.650% Notes due 2030 on July 10, 2026, increasing total outstanding 2030 Notes to $400.0 million. The notes were issued under an underwriting agreement with SMBC Nikko Securities America, Inc. and will be used primarily to repay outstanding indebtedness under its senior secured revolving credit facility with Sumitomo Mitsui Banking Corporation, with re-borrowings intended for investments and general corporate purposes. The offering was upsized from the original $300.0 million issuance in January 2025, reflecting continued access to debt capital markets, though the notes carry a fixed 6.650% coupon that adds to the company's interest expense obligations.
- · The Additional 2030 Notes are fungible with and rank equally to the Existing 2030 Notes, sharing the same CUSIP number.
- · Interest on the 2030 Notes is payable semi-annually on March 15 and September 15, with the first payment for the Additional Notes on September 15, 2026.
- · The notes mature on March 15, 2030 and may be redeemed at the company's option at any time prior to February 15, 2030 at par plus a make-whole premium plus accrued interest.
- · The 2030 Notes are unsecured and rank pari passu with all existing and future unsubordinated unsecured debt, but are effectively subordinated to secured indebtedness and structurally subordinated to obligations of subsidiaries.
- · The Indenture includes covenants requiring compliance with Section 18(a)(1)(A) as modified by Section 61(a) of the 1940 Act, and to provide financial information to noteholders if the company ceases to be subject to Exchange Act reporting.
10-07-2026
Transportation & Logistics Systems (TLSS) entered into a Second Amendment to its agreement to acquire Patriot Glass Solutions (PGS) via a reverse triangular merger, extending key deadlines to August 4, 2026. The $4.75M consideration will be paid in 47,500 shares of TLSS Series J Senior Convertible Preferred Stock. The acquisition is part of TLSS's strategy to become a leader in safety and security technology, leveraging PGS's window tint solutions and C-Bond nanotechnology patents.
- · The Second Amendment extends the Schedule Delivery Date and financial statement deadline to July 15, 2026, full access and deliverables deadline to July 24, 2026, and outside closing date to August 4, 2026.
- · The acquisition includes four nanotechnology patents related to C-Bond applications.
- · Mercer Street Global Opportunity Fund, LLC is an existing preferred stockholder of TLSS.
- · Closing conditions include satisfactory due diligence, accuracy of representations, landlord consent for PGS lease assignment, and delivery of audited financials for 2024 and 2025 and unaudited financials for first two quarters of 2026.
- · Michael Wanke will enter into an employment agreement with PGS as a condition of closing.
10-07-2026
ZyVersa Therapeutics disclosed that independent director Min Chul Park, Ph.D. resigned effective July 8, 2026, for personal reasons and not due to any disagreement with the company. The company is exploring cost-cutting measures including voluntary pay reductions by CEO Stephen Glover and CFO Peter Wolfe, possible divestiture of product candidates VAR 200 or IC 100, employee headcount reductions, and considering going dark by suspending SEC filing obligations. While management is taking steps to preserve cash, the measures signal significant financial distress, with no new financing secured yet.
- · CEO Stephen Glover and CFO Peter Wolfe each voluntarily agreed to accept reduced compensation to support the company during a period of limited cash resources.
- · The company is considering divesting or selling its VAR 200 or IC 100 product candidates.
- · Employee headcount reduction is being considered to focus on core services and support.
- · The company may 'go dark' by suspending its obligations to file periodic reports under the Securities Exchange Act of 1934.
- · Other alternatives such as sale of the company or its assets, restructuring, or reorganization are also being considered.
- · The company expects any savings from cost-reduction activities along with any capital raise may enable continued operations, but no new financing has been secured yet.
10-07-2026
XMax Inc. (XWIN) disclosed that its wholly owned subsidiary, Xmax Beta Holdings Ltd., entered into a Subscription Agreement on July 6, 2026, to make an additional subscription of $8,770,000 in Preamble X Capital I, increasing its interest to over 99.9%. The subscription was completed on July 7, 2026, and the management fee for the Company is 0%. This transaction effectively consolidates the Company's control over the investment vehicle.
- · The subsidiary Xmax Beta Holdings Ltd. is incorporated in the Cayman Islands.
- · Preamble X Capital I is a series of Preamble X Capital LLC, a Delaware LLC.
- · Allocations Fund Administration, LLC serves as the administrative manager of Preamble X Capital I.
- · The filing was made under Items 1.01, 2.01, and 9.01 of Form 8-K.
10-07-2026
Dana Inc. entered into Amendment No. 8 to its Credit and Guaranty Agreement, establishing a new $500.0 million incremental senior secured delayed draw term loan A facility (the 2026 Delayed Draw Term A Facility) and increasing the Inside Maturity Basket to the greater of $500 million and 8.25% of Total Assets. The amendment was consented to by the required lenders and became effective on July 10, 2026, subject to standard conditions including no Material Adverse Effect since December 31, 2025. The company also affirmed its existing guarantees and collateral pledges.
- · The amendment is the 8th modification to the original Credit and Guaranty Agreement dated June 9, 2016.
- · The 2026 Delayed Draw Term A Facility is an incremental senior secured delayed draw term loan A facility.
- · The Inside Maturity Basket increase is to the greater of $500,000,000 and 8.25% of Total Assets.
- · Conditions precedent include no Material Adverse Effect since December 31, 2025, and delivery of solvency certificates, legal opinions, and KYC documentation.
- · The amendment was consented to by the Required Lenders under the Existing Credit Agreement.
10-07-2026
KBR, Inc. entered into amended and restated severance and change in control agreements with its executive officers, including the CEO and CFO, effective July 10, 2026. The amendments enhance severance multiples for non-CEO executives from 1.0x to 1.5x (base salary + target bonus), broaden the definition of 'Good Reason,' and clarify 'Cause' definitions, while also adding retirement eligibility criteria and pro-rata RSU vesting. The changes aim to provide fair and competitive treatment but do not materially modify change-in-control benefits.
- · The Galindo Agreement includes additional non-change-in-control severance enhancements: pro-rata annual bonus, pro-rata vesting of non-performance equity awards, and pro-rata vesting of performance-based awards.
- · The Galindo Agreement's non-compete clause includes an exception for the right to practice law.
- · Retirement eligibility requires sum of age and years of service ≥ 70, with minimum age 55 and at least 5 years of service, plus 6 months' prior written notice.
- · The agreements do not materially modify change-in-control severance payments and benefits.
10-07-2026
Peraso Inc. entered into a letter agreement with Roth Principal Investments, LLC on July 10, 2026, adjusting the purchase price discount for Pre-Market and Post-Market Purchases under the existing Common Stock Purchase Agreement to 5.0% of VWAP. The amendment is a condition for commencing sales under the facility, while all other terms of the Purchase Agreement remain unchanged.
- · The letter agreement was a condition for the commencement of sales under the Purchase Agreement.
- · The Purchase Agreement was originally dated June 30, 2026.
- · The discount applies to both Pre-Market and Post-Market Purchases.
- · The agreement includes a provision to exclude sales below a minimum price threshold if a Limit Order Continue Election is specified.
10-07-2026
American Battery Technology Company (ABAT) entered into new two-year employment agreements with its CEO/CTO Ryan Melsert, CFO Alejandro Flores Arteaga, and COO Steven Wu, effective July 1, 2026. The agreements include annual salaries of $475,000 (CEO), $280,000 (CFO), and $350,000 (COO), plus performance-based cash bonuses (75% of salary target), RSUs ($1M CEO, $500K CFO, $750K COO), and stock options (3M, 1M, and 1.5M shares respectively at $2.76 per share). The compensation packages are designed to retain key executives and align incentives with strategic milestones, though no prior-period comparisons are available to assess changes.
- · Stock option exercise price is $2.76 per share, based on closing price on July 1, 2026.
- · RSUs and options vest 1/16th quarterly; FY2027 grants vest from July 1, 2026, FY2028 grants from July 1, 2027.
- · CEO options expire July 1, 2036 (FY2027) and July 1, 2037 (FY2028); CFO and COO options have same expiry dates.
- · Compensation Committee engaged an independent consultant and performed a market assessment before approving agreements.
- · No prior employment agreements or compensation data provided for period-over-period comparison.
10-07-2026
Jones Soda Co. closed a private placement offering of units, each consisting of one common share and one-half of a detachable warrant, for aggregate gross proceeds of $1,735,000. The company intends to use the net proceeds for growth and general corporate purposes. Revere Securities LLC acted as a finder and received an 8.0% cash fee and warrants equal to 8.0% of the units issued.
- · The offering was not registered under the U.S. Securities Act of 1933, but the common shares and underlying warrant shares include registration rights.
- · The company is listed on the CSE and OTCQB under the symbol JSDA.
10-07-2026
iQSTEL Inc. entered into a Contribution Agreement on July 8, 2026, to execute an internal corporate realignment, contributing assets, equity interests, and operations into newly formed or existing subsidiaries to streamline its corporate structure and improve operational efficiency. The realignment focuses on the company's fintech, AI, and digital services business lines but does not involve any change in management, board, or overall business operations, and is not expected to have a material impact on consolidated financial statements.
- · The Contribution Agreement was entered into on July 8, 2026, and filed on July 10, 2026.
- · The realignment involves contributions of assets, equity interests, and operations into newly formed or existing subsidiaries.
- · The realignment is intended to streamline corporate structure and improve operational efficiency across fintech, AI, and digital services operations.
- · The agreement contains customary representations, warranties, covenants, and indemnification provisions.
- · The full text of the Contribution Agreement will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ending June 30, 2026.
10-07-2026
Forward Air Corp announced that Jerome Lorrain resigned as Executive Chairman effective July 10, 2026, but will remain on the Board as a non-employee director. His outstanding restricted stock awards will continue to vest while he serves on the Board, but his performance-based and special one-time equity awards tied to the strategic review were forfeited. The Board appointed independent director Christine M. Gorjanc as the new Chair.
- · Mr. Lorrain did not receive an annual equity award for 2026 under the non-employee director compensation program.
- · No compensatory arrangement was entered into other than the amendments to restricted stock award agreements.
- · Ms. Gorjanc's appointment was not made pursuant to any arrangement with any other person and no transactions require disclosure under Item 404(a).
10-07-2026
Via Transportation, Inc. announced the appointment of Matt Levine as Chief Legal Officer, effective July 27, 2026, succeeding Erin Abrams who will step down and transition to a senior advisory role until January 1, 2027. Matt Levine brings extensive legal and privacy experience from his prior roles at Clear Secure, Inc. and Success Academy Charter Schools. Erin Abrams, who has served Via since 2014, will ensure continuity during the transition.
- · Matt Levine previously served as General Counsel and Chief Privacy Officer at Clear Secure, Inc. from 2012 to 2024.
- · Erin Abrams will serve in a senior advisory role until January 1, 2027.
- · Erin Abrams joined Via in 2014, providing twelve years of service.
10-07-2026
Sunshine Biopharma Inc. and its subsidiary Nora Pharma Inc. entered into a settlement and mutual release agreement with former Nora president Malek Chamoun on July 8, 2026, paying CAD $1,500,000 (approx. US $1,058,565) to resolve a dispute over earn-out payments, bonuses, termination indemnity, and expense reimbursements. The settlement also releases Chamoun from non-competition and non-solicitation obligations, while he must sell all his Sunshine common shares within 30 days. The agreement avoids litigation but represents a cash outflow for the company with no offsetting revenue or operational benefit.
- · The dispute arose from a draft Originating Application sent by Chamoun on May 22, 2026, claiming amounts under the SPA for loss in share value, employment termination indemnities, and moral/punitive damages.
- · The Corporations had cross-claims against Chamoun related to licensing/supply agreements, commissions, and related-party transactions during his tenure.
- · Settlement payment is to be paid within 10 days after Chamoun provides written evidence of selling all his Sunshine common shares.
- · Chamoun is released from all non-competition and non-solicitation obligations under the Employment Agreement and Non-Compete Agreement, but confidentiality obligations remain.
- · Each party bears its own legal fees and disbursements.
10-07-2026
Lincoln Educational Services Corp's subsidiary, Lincoln Technical Institute, Inc., entered into a $15,040,000 loan agreement with Provident Bank on July 7, 2026, to finance the acquisition of a mortgaged property and related closing costs. The loan is secured by the property and guaranteed by the parent company and three acquisition-related LLCs. The filing confirms the loan is permitted under the company's existing Fifth Third credit agreement and does not indicate any adverse financial trends or defaults.
- · The loan is secured by a Mortgage, Assignment of Leases and Rents, and UCC fixture filings on the property.
- · Guarantors include the parent company and three acquisition LLCs: New England Acquisition, LLC, NN Acquisition, LLC, and Nashville Acquisition, L.L.C.
- · The loan is intended to be permitted Indebtedness under the existing Fifth Third Credit Agreement; no conflict or default arises from the existing credit facility.
- · The Borrower paid a $75,200 loan fee at closing.
Get daily alerts with 11 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Material Events SEC 8-K Filings
🇺🇸 More from United States
View all →July 10, 2026
US Pre-Market SEC Filings Roundup — July 10, 2026
US Pre-Market SEC Filings Roundup
July 10, 2026
Global High-Priority Regulatory Events — July 10, 2026
Global High-Priority Regulatory Events
July 10, 2026
US Earnings Financial Results SEC Filings — July 10, 2026
US Earnings Financial Results SEC Filings
July 10, 2026
US Executive Compensation Proxy SEC Filings — July 10, 2026
US Executive Compensation Proxy SEC Filings